Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Meeting on the Med 2021 and Cell Therapy
View overview page
4:25
Building the advanced therapies workforce in the UK
Matthew Durdy
• 9 Apr 2021
3:31
The state of investment in cell & gene therapy
Matthew Durdy
• 9 Apr 2021
3:41
Improving patient access to advanced therapies: are we ready for them?
Durhane Wong-Rieger
• 6 Apr 2021
2:58
ATA188 in EBV+ progressive multiple sclerosis
Pascal Touchon
• 7 Apr 2021
2:56
International collaboration in advanced therapies
Amy DuRoss
• 8 Apr 2021
2:48
Supply chain management & automation
Amy DuRoss
• 8 Apr 2021
2:45
What can the field learn from the COVID-19 pandemic?
Amy DuRoss
• 8 Apr 2021
1:14
The importance of specialty medical centers in delivering ATMPs
Paige Bischoff
• 11 Mar 2021
4:06
Shaping the future of CMC in cell & gene therapy
Stephen Ward
• 14 Apr 2021
3:24
Advancing the sector: training, scalability & materials standardization
Stephen Ward
• 14 Apr 2021
3:43
Horizon scanning for the UK cell & gene therapy sector
Stephen Ward
• 14 Apr 2021
3:10
The lasting impact of COVID-19 on the CGT sector
Stephen Ward
• 14 Apr 2021
3:06
Targeting solid tumors: SPEAR T-cells & HLA-independent TCRs
Jo Brewer
• 7 Apr 2021
1:09
SPEARHEAD-1: ADP-A2M4 in synovial sarcoma and MRCLS
Jo Brewer
• 7 Apr 2021
1:22
SURPASS: evaluating the next-generation of SPEAR T-cell therapy
Jo Brewer
• 7 Apr 2021
4:23
Off-the-shelf iPSC therapies for solid tumors
Jo Brewer
• 7 Apr 2021
1
2
3
Next